LMU spin-off using programmable DNA-origami nanostructures to amplify signals of lateral-flow assays (LFAs), reportedly increasing sensitivity up to 100x to enable PCR-like diagnostics at point-of-care.
Investment Rounds
Capital activity and funding progression
| Amount | Date | Round |
|---|---|---|
| €5 M | Dec, 2025 | seed |
Frequently Asked Questions
What industries does Amplifold GmbH operate in?
Amplifold GmbH operates in the following industries: biotechnology, diagnostics, medical-devices, dna-nanotechnology.
How much total funding has Amplifold GmbH raised?
Amplifold GmbH has raised a total of $5,000,000.
Who are the investors in Amplifold GmbH?
The investors in Amplifold GmbH are: Xista Science Ventures, Becker Ventures (Labor Becker Gruppe), Bayern Kapital.